Hypercoagulability.
D000991:Antithrombins / Q000494:pharmacology; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000378:metabolism; D001792:Blood Platelets; D002470:Cell Survival; D005165:Factor V / Q000096:biosynthesis; D005167:Factor VII / Q000096:biosynthesis; D005169:Factor VIII / Q000096:biosynthesis; D005174:Factor XII / Q000096:biosynthesis; D005337:Fibrin / Q000378:metabolism; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D005344:Fibrinopeptide A / Q000378:metabolism; D005345:Fibrinopeptide B / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D012157:Mononuclear Phagocyte System / Q000378:metabolism; D010974:Platelet Aggregation; D013927:Thrombosis / Q000097:blood; D000515:alpha 1-Antitrypsin / Q000494:pharmacology; D000511:alpha-Macroglobulins / Q000494:pharmacology
D000991:Antithrombins; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D005165:Factor V; D005167:Factor VII; D005169:Factor VIII; D005174:Factor XII; D005337:Fibrin; D005340:Fibrinogen